Gremubamab (MEDI3902) is a humanised monoclonal antibody targeting PcrV/Psl, exhibiting bivalent and bispecific properties. It binds to both the PAPcrV protein and Psl extracellular polysaccharide, making it suitable for studying Pseudomonas aeruginosa infections.
Purity:
95.00%
CAS Number:
[1800381-36-5]
Target:
Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted